HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cinzia Dello Russo Selected Research

Macrocyclic Lactams

2/2013The novel HSP90 inhibitor, PU-H71, suppresses glial cell activation but weakly affects clinical signs of EAE.
2/2002Suppressive effects of ansamycins on inducible nitric oxide synthase expression and the development of experimental autoimmune encephalomyelitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Cinzia Dello Russo Research Topics

Disease

6Neoplasms (Cancer)
01/2021 - 07/2014
4Multiple Sclerosis
01/2021 - 11/2005
4Pain (Aches)
12/2020 - 03/2009
4Glioma (Gliomas)
01/2017 - 08/2002
4Hypersensitivity (Allergy)
05/2016 - 04/2011
4Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
03/2013 - 02/2002
3Disease Progression
03/2013 - 11/2005
2Alzheimer Disease (Alzheimer's Disease)
05/2022 - 10/2003
2Nervous System Diseases (Neurological Disorders)
01/2019 - 01/2012
2Inflammation (Inflammations)
01/2012 - 11/2002
2Migraine Disorders (Migraine)
05/2011 - 08/2009
2Neuroinflammatory Diseases
11/2009 - 02/2002
1Cognitive Dysfunction
05/2022
1Lymphopenia (Lymphocytopenia)
01/2021
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2019
1Neuroblastoma
09/2015
1Chronic Pain
01/2015
1Cancer Pain
01/2015
1Neuralgia (Stump Neuralgia)
01/2015
1Hyperalgesia
03/2013
1Acquired Immunodeficiency Syndrome (AIDS)
01/2012
1Infections
01/2012
1Hypoxia (Hypoxemia)
11/2009
1Encephalitis (Encephalitis, Rasmussen)
11/2009
1Demyelinating Diseases (Demyelinating Disease)
11/2005
1Brain Neoplasms (Brain Tumor)
03/2004
1Brain Diseases (Brain Disorder)
11/2002
1Wounds and Injuries (Trauma)
02/2002

Drug/Important Bio-Agent (IBA)

5Pharmaceutical PreparationsIBA
01/2021 - 11/2005
4abacavir (Ziagen)FDA Link
05/2016 - 04/2011
3Norepinephrine (Noradrenaline)FDA LinkGeneric
05/2022 - 11/2002
3Sirolimus (Rapamycin)FDA Link
01/2019 - 03/2013
3HLA-B57 antigenIBA
05/2016 - 04/2011
3Phosphotransferases (Kinase)IBA
01/2015 - 03/2013
3CytokinesIBA
04/2011 - 11/2002
2Dimethyl FumarateIBA
01/2021 - 04/2011
2LigandsIBA
01/2019 - 11/2005
2TOR Serine-Threonine KinasesIBA
01/2015 - 07/2014
2Proteins (Proteins, Gene)FDA Link
01/2015 - 01/2012
2Macrocyclic LactamsIBA
02/2013 - 02/2002
2Calcitonin Gene-Related PeptideIBA
08/2011 - 08/2009
2LipopolysaccharidesIBA
04/2011 - 03/2004
2Nitric Oxide Synthase (NO Synthase)IBA
11/2009 - 02/2002
2Nitric Oxide (Nitrogen Monoxide)FDA Link
11/2009 - 02/2002
1ChemokinesIBA
05/2022
1Neuroprotective AgentsIBA
05/2022
1Neurotransmitter Agents (Neurotransmitter)IBA
12/2020
1Nerve Growth Factors (Neurotrophins)IBA
12/2020
1Brain-Derived Neurotrophic Factor (BDNF)IBA
12/2020
1pembrolizumabIBA
01/2019
1gamma-glutamylaminomethylsulfonic acid (GAMS)IBA
01/2017
1Corticotropin-Releasing Hormone Receptors (Corticotropin Releasing-Hormone Receptor)IBA
09/2015
1Corticotropin-Releasing HormoneIBA
09/2015
1Cyclin-Dependent Kinase Inhibitor p27IBA
09/2015
1Messenger RNA (mRNA)IBA
09/2015
1EverolimusFDA Link
07/2014
1Interleukin-10 (Interleukin 10)IBA
07/2014
1Conditioned Culture MediaIBA
07/2014
16- amino- 8- ((6- iodo- 1,3- benzodioxol- 5- yl)thio)- N- (1- methylethyl)- 9H-purine-9-propanamineIBA
02/2013
1MaravirocFDA Link
01/2012
1Chemokine ReceptorsIBA
01/2012
1Sumatriptan (Imigran)FDA LinkGeneric
05/2011
1BradykininIBA
05/2011
1Tryptamines (Triptans)IBA
05/2011
1NitritesIBA
04/2011
1InterferonsIBA
04/2011
1Transcription Factors (Transcription Factor)IBA
04/2011
1Glucose (Dextrose)FDA LinkGeneric
11/2009
1Oxygen (Dioxygen)IBA
11/2009
1Opioid Analgesics (Opioids)IBA
03/2009
1Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
03/2009
1Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA
03/2009
1Analgesics (Analgesic Drugs)IBA
03/2009
1Formaldehyde (Formol)FDA Link
03/2009
1tanespimycin (17AAG)IBA
12/2006
1Heat-Shock Proteins (Heat-Shock Protein)IBA
12/2006
1geldanamycinIBA
12/2006
1PPAR deltaIBA
11/2005
1Peroxisome Proliferator-Activated Receptors (PPAR)IBA
11/2005
1(4- (((2- (3- fluoro- 4- (trifluoromethyl)phenyl)- 4- methyl- 1,3- thiazol- 5- yl)methyl)sulfanyl)- 2- methylphenoxy)acetic acidIBA
11/2005
1PPAR gammaIBA
11/2005
1Methotrexate (Mexate)FDA LinkGeneric
03/2004
1Antineoplastic Agents (Antineoplastics)IBA
03/2004
1Temozolomide (Temodar)FDA LinkGeneric
03/2004
1Immunologic Factors (Immunomodulators)IBA
11/2002
1Cytokine Receptors (Cytokine Receptor)IBA
11/2002
1I-kappa B Proteins (I kappa B)IBA
08/2002
1Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA
08/2002
1NF-kappa B (NF-kB)IBA
08/2002
1Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
02/2002
1Protein Isoforms (Isoforms)IBA
02/2002

Therapy/Procedure

3Therapeutics
01/2021 - 05/2011
1Highly Active Antiretroviral Therapy (HAART)
01/2012
1Secondary Prevention
04/2011
1Drug Therapy (Chemotherapy)
03/2004